AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Bill Tracker · New York

S8925

7-OH product restrictions

Status

Pending

2025–2026

Passed both chambers in retrieved history; no governor signature confirmed. Targets 7-OH above 2% of total alkaloids or 1 mg per serving, not a blanket whole-leaf ban.

IntroducedJan 16, 2026 (done)
PassedJun 5, 2026 (done)
SignedNext step (current)
Law in effect— (upcoming)

Type: Official legislature record
Substances: Kratom / 7-OH

Official text

Summary of official legislation

Passed both chambers in retrieved history; no governor signature confirmed. Targets 7-OH above 2% of total alkaloids or 1 mg per serving, not a blanket whole-leaf ban.

The full bill text and every version are kept by the legislature. We link to it rather than copy it so readers always see the current version.

Read the full bill text

Source: nysenate.gov

Legislative history

June 5, 2026
Passed Assembly and returned to Senate.
January 16, 2026
Introduced.

Loading bill…